• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于血管造影的冠状动脉功能评估可预测急性心肌梗死后30天内新发心力衰竭。

Angio-based coronary functional assessment predicts 30-day new-onset heart failure after acute myocardial infarction.

作者信息

Luo Da, Wu Hui, Zhou Wenjie, Zhang Jing, Jin Xing, Xu Changwu, Huang Bing, Yang Jian, Jiang Hong, Chen Jing

机构信息

Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan, China.

Cardiovascular Research Institute of Wuhan University, Wuhan, China.

出版信息

ESC Heart Fail. 2023 Oct;10(5):2914-2926. doi: 10.1002/ehf2.14452. Epub 2023 Jul 16.

DOI:10.1002/ehf2.14452
PMID:37455355
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10567646/
Abstract

AIMS

Suboptimal perfusion leading to heart failure (HF) often occurs after ST-segment elevation myocardial infarction (STEMI), despite restoration of epicardial coronary flow in primary percutaneous coronary intervention (PPCI) era. We determined the clinical implications of angio-based coronary functional assessment in evaluation of suboptimal perfusion and further outcomes among STEMI patients after successful PPCI.

METHODS AND RESULTS

In this study, STEMI patients in the Chinese STEMI PPCI registry trial (NCT04996901) who achieved post-PPCI thrombolysis in myocardial infarction grade 3 flow were retrospectively screened. Post-procedural quantitative flow ratio (QFR), angio-based microvascular resistance (AMR), and coronary flow velocity (CFV) of the infarct-related artery were calculated. QFR and AMR measure epicardial stenosis severity and microvascular resistance, respectively. QFR+ was defined as QFR < 0.90 while QFR- was QFR ≥ 0.90. AMR+ was defined as AMR ≥ 250 mmHgs/m while AMR- was AMR < 250 mmHgs/m. The primary outcome was 30-day new-onset HF. The Kaplan-Meier curves were used to establish the associations between QFR, AMR, CFV, and HF incidences. The relationship between CFV and combined QFR and AMR indices was further assessed. Independent predictors were determined using Cox regression analysis. The receiver-operating characteristic curve was used to assess discriminant ability to predict HF. A total of 942 patients (mean age was 57.8 ± 11.7 years and 84.6% were men) were enrolled. Among them, 129 patients had new-onset HF episodes. Patients in the QFR-/AMR- group had a low risk of HF compared with those in the QFR+/AMR+ group (10.5% vs. 27.3%, P = 0.027). A higher CFV ≥ 17.4 cm/s was associated with low HF incidences as compared with CFV < 17.4 cm/s (10.3% vs. 16.8%, P = 0.005), whereas isolated QFR or AMR did not reveal any marked differences in HF incidences (P = 0.150 and 0.079, respectively). The highest and lowest medians of CFV were observed in the QFR-/AMR- and QFR+/AMR+ groups, respectively. CFV correlated well with the QFR/AMR ratio (adjusted R  = 1, P < 0.001) and post-PPCI CFV was found to be an independent predictor of post-STEMI HF (adjusted hazard ratio: 0.61, 95% confidence interval: 0.41-0.90, P = 0.012). The area under curve estimate of the multivariable regression model was 0.749.

CONCLUSIONS

CFV is an integrated coronary physiological assessment approach that incorporates epicardial and microcirculatory contributions. Patients with post-PPCI CFV < 17.4 cm/s were strongly associated with a high risk for post-STEMI HF, even achieving thrombolysis in myocardial infarction grade 3 flow. The immediate angio-based coronary functional assessment is a feasible tool for evaluating suboptimal perfusion and risk stratification.

摘要

目的

尽管在直接经皮冠状动脉介入治疗(PPCI)时代已恢复心外膜冠状动脉血流,但ST段抬高型心肌梗死(STEMI)后仍常发生导致心力衰竭(HF)的灌注不足。我们确定了基于血管造影的冠状动脉功能评估在评估STEMI患者PPCI成功后灌注不足及进一步预后中的临床意义。

方法与结果

在本研究中,对中国STEMI PPCI注册试验(NCT04996901)中PPCI术后达到心肌梗死溶栓3级血流的STEMI患者进行回顾性筛查。计算梗死相关动脉的术后定量血流比(QFR)、基于血管造影的微血管阻力(AMR)和冠状动脉血流速度(CFV)。QFR和AMR分别测量心外膜狭窄严重程度和微血管阻力。QFR+定义为QFR < 0.90,而QFR-定义为QFR≥0.90。AMR+定义为AMR≥250 mmHgs/m,而AMR-定义为AMR < 250 mmHgs/m。主要结局为30天新发HF。采用Kaplan-Meier曲线确定QFR、AMR、CFV与HF发生率之间的关联。进一步评估CFV与联合QFR和AMR指数之间的关系。使用Cox回归分析确定独立预测因素。采用受试者工作特征曲线评估预测HF的判别能力。共纳入942例患者(平均年龄为57.8±11.7岁,84.6%为男性)。其中,129例患者发生新发HF事件。与QFR+/AMR+组相比,QFR-/AMR-组患者发生HF的风险较低(10.5%对27.3%,P = 0.027)。与CFV < 17.4 cm/s相比,CFV≥17.4 cm/s与较低的HF发生率相关(10.3%对16.8%,P = 0.005),而单独的QFR或AMR在HF发生率上未显示出任何显著差异(分别为P = 0.150和0.079)。CFV的最高和最低中位数分别在QFR-/AMR-组和QFR+/AMR+组中观察到。CFV与QFR/AMR比值相关性良好(调整后R = 1,P < 0.001),且发现PPCI术后CFV是STEMI后HF的独立预测因素(调整后风险比:0.61,95%置信区间:0.41 - 0.90,P = 0.012)。多变量回归模型的曲线下面积估计值为0.749。

结论

CFV是一种综合的冠状动脉生理评估方法,融合了心外膜和微循环的作用。PPCI术后CFV < 17.4 cm/s的患者与STEMI后HF的高风险密切相关,即使达到心肌梗死溶栓3级血流。即时基于血管造影的冠状动脉功能评估是评估灌注不足和风险分层的可行工具。

相似文献

1
Angio-based coronary functional assessment predicts 30-day new-onset heart failure after acute myocardial infarction.基于血管造影的冠状动脉功能评估可预测急性心肌梗死后30天内新发心力衰竭。
ESC Heart Fail. 2023 Oct;10(5):2914-2926. doi: 10.1002/ehf2.14452. Epub 2023 Jul 16.
2
A simple angio-based coronary flow assessment of culprit vessels in primary percutaneous coronary intervention is associated with long-term prognosis after ST-segment-elevation myocardial infarction.直接经皮冠状动脉介入治疗罪犯血管的简单血管造影血流评估与 ST 段抬高型心肌梗死的长期预后相关。
Int J Cardiol. 2024 Aug 15;409:132199. doi: 10.1016/j.ijcard.2024.132199. Epub 2024 May 22.
3
Clinical implication of QFR in patients with ST-segment elevation myocardial infarction after drug-eluting stent implantation.药物洗脱支架置入术后 ST 段抬高型心肌梗死患者血流储备分数的临床意义。
Int J Cardiovasc Imaging. 2021 Mar;37(3):755-766. doi: 10.1007/s10554-020-02068-0. Epub 2020 Oct 12.
4
Smoking paradox in coronary function and structure of acute ST-segment elevation myocardial infarction patients treated with primary percutaneous coronary intervention.急性 ST 段抬高型心肌梗死患者行直接经皮冠状动脉介入治疗后冠状动脉功能和结构的吸烟悖论。
BMC Cardiovasc Disord. 2024 Aug 14;24(1):427. doi: 10.1186/s12872-024-04093-6.
5
Efficacy and Safety of a Pharmaco-Invasive Strategy With Half-Dose Alteplase Versus Primary Angioplasty in ST-Segment-Elevation Myocardial Infarction: EARLY-MYO Trial (Early Routine Catheterization After Alteplase Fibrinolysis Versus Primary PCI in Acute ST-Segment-Elevation Myocardial Infarction).半剂量阿替普酶与直接经皮冠状动脉介入治疗在 ST 段抬高型心肌梗死中的疗效和安全性:EARLY-MYO 试验(阿替普酶溶栓后早期常规冠状动脉造影与急性 ST 段抬高型心肌梗死直接经皮冠状动脉介入治疗的比较)。
Circulation. 2017 Oct 17;136(16):1462-1473. doi: 10.1161/CIRCULATIONAHA.117.030582. Epub 2017 Aug 27.
6
Novel application of quantitative flow ratio for predicting microvascular dysfunction after ST-segment-elevation myocardial infarction.定量血流比在预测 ST 段抬高型心肌梗死后微血管功能障碍中的新应用。
Catheter Cardiovasc Interv. 2020 Feb;95 Suppl 1:624-632. doi: 10.1002/ccd.28718. Epub 2020 Jan 8.
7
Prevalence and Predictive Value of Microvascular Flow Abnormalities after Successful Contemporary Percutaneous Coronary Intervention in Acute ST-Segment Elevation Myocardial Infarction.急性 ST 段抬高型心肌梗死患者经当代经皮冠状动脉介入治疗成功后微血管血流异常的发生率及预测价值。
J Am Soc Echocardiogr. 2018 Jun;31(6):674-682. doi: 10.1016/j.echo.2018.01.009. Epub 2018 Mar 7.
8
Prognostic value of angiographic microvascular resistance in patients with ST-segment elevation myocardial infarction.ST 段抬高型心肌梗死患者血管造影微血管阻力的预后价值。
Clinics (Sao Paulo). 2024 Jul 24;79:100429. doi: 10.1016/j.clinsp.2024.100429. eCollection 2024.
9
Quantitative Flow Ratio Identifies Nonculprit Coronary Lesions Requiring Revascularization in Patients With ST-Segment-Elevation Myocardial Infarction and Multivessel Disease.定量血流比可识别 ST 段抬高型心肌梗死和多支血管病变患者中需要血运重建的罪犯性冠状动脉病变。
Circ Cardiovasc Interv. 2018 Feb;11(2):e006023. doi: 10.1161/CIRCINTERVENTIONS.117.006023.
10
Angiography-derived index of microcirculatory resistance as a novel, pressure-wire-free tool to assess coronary microcirculation in ST elevation myocardial infarction.血管造影衍生的微循环阻力指数作为一种新型的、无压力导丝的工具,用于评估 ST 段抬高型心肌梗死患者的冠状动脉微循环。
Int J Cardiovasc Imaging. 2020 Aug;36(8):1395-1406. doi: 10.1007/s10554-020-01831-7. Epub 2020 May 14.

引用本文的文献

1
Development and validation of an AMR-based predictive model for post-PCI contrast-induced nephropathy in patients with acute ST-segment elevation myocardial infarction.急性ST段抬高型心肌梗死患者经皮冠状动脉介入治疗后对比剂肾病基于抗菌药物耐药性的预测模型的开发与验证
Front Cardiovasc Med. 2025 Jun 26;12:1552762. doi: 10.3389/fcvm.2025.1552762. eCollection 2025.
2
Analysis of Metabolic Risk Factors for Microcirculation Disorders Post-Percutaneous Coronary Intervention and Predictive Model Construction: A Study on Patients with Unstable Angina.经皮冠状动脉介入治疗后微循环障碍的代谢危险因素分析及预测模型构建:一项关于不稳定型心绞痛患者的研究
Rev Cardiovasc Med. 2025 Jan 8;26(1):25739. doi: 10.31083/RCM25739. eCollection 2025 Jan.
3

本文引用的文献

1
Effects of early myocardial reperfusion and perfusion on myocardial necrosis/dysfunction and inflammation in patients with ST-segment and non-ST-segment elevation acute coronary syndrome: results from the PLATelet inhibition and patients Outcomes (PLATO) trial.ST 段抬高和非 ST 段抬高急性冠状动脉综合征患者早期心肌再灌注和灌注对心肌坏死/功能障碍和炎症的影响:来自血小板抑制和患者结局(PLATO)试验的结果。
Eur Heart J Acute Cardiovasc Care. 2022 Jun 7;11(4):336-349. doi: 10.1093/ehjacc/zuac020.
2
Heart Failure Incidence Following ST-Elevation Myocardial Infarction.ST 段抬高型心肌梗死患者的心力衰竭发生率。
Am J Cardiol. 2022 Feb 1;164:14-20. doi: 10.1016/j.amjcard.2021.10.035. Epub 2021 Nov 21.
3
Integrating the GRACE Score with the Ceramide Risk Score Enhances the Predictive Accuracy of Major Adverse Cardiac Events in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.
将GRACE评分与神经酰胺风险评分相结合可提高接受经皮冠状动脉介入治疗的急性冠状动脉综合征患者主要不良心脏事件的预测准确性。
Rev Cardiovasc Med. 2024 Dec 31;26(1):25984. doi: 10.31083/RCM25984. eCollection 2025 Jan.
4
Association between admission blood pressure and spontaneous reperfusion and long-term prognosis in STEMI patients: an observational and multicenter study.急性 ST 段抬高型心肌梗死患者入院血压与自发性再灌注及长期预后的关系:一项观察性多中心研究。
BMC Cardiovasc Disord. 2024 Sep 18;24(1):500. doi: 10.1186/s12872-024-04168-4.
5
Diagnostic and prognostic value of angiography-derived index of microvascular resistance: a systematic review and meta-analysis.血管造影衍生的微血管阻力指数的诊断和预后价值:一项系统评价和荟萃分析。
Front Cardiovasc Med. 2024 Apr 15;11:1360648. doi: 10.3389/fcvm.2024.1360648. eCollection 2024.
Angiographic quantitative flow ratio-guided coronary intervention (FAVOR III China): a multicentre, randomised, sham-controlled trial.
血管造影定量血流比指导的冠状动脉介入治疗(FAVOR III China):一项多中心、随机、假手术对照试验。
Lancet. 2021 Dec 11;398(10317):2149-2159. doi: 10.1016/S0140-6736(21)02248-0. Epub 2021 Nov 4.
4
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure.2021年欧洲心脏病学会急性和慢性心力衰竭诊断与治疗指南。
Eur Heart J. 2021 Sep 21;42(36):3599-3726. doi: 10.1093/eurheartj/ehab368.
5
Functional Coronary Angiography-Derived Index of Microcirculatory Resistance in Patients With ST-Segment Elevation Myocardial Infarction.功能冠状动脉造影衍生的 ST 段抬高型心肌梗死患者的微循环阻力指数。
JACC Cardiovasc Interv. 2021 Aug 9;14(15):1670-1684. doi: 10.1016/j.jcin.2021.05.027.
6
Coronary Microvascular Dysfunction Assessed by Pressure Wire and CMR After STEMI Predicts Long-Term Outcomes.经皮冠状动脉介入治疗后通过压力导丝和 CMR 评估的冠状动脉微血管功能障碍可预测远期结局。
JACC Cardiovasc Imaging. 2021 Oct;14(10):1948-1959. doi: 10.1016/j.jcmg.2021.02.023. Epub 2021 Apr 14.
7
Diagnostic accuracy of quantitative flow ratio for assessment of coronary stenosis significance from a single angiographic view: A novel method based on bifurcation fractal law.定量血流比评估单支血管造影下冠状动脉狭窄意义的诊断准确性:一种基于分叉分形律的新方法。
Catheter Cardiovasc Interv. 2021 May 1;97 Suppl 2:1040-1047. doi: 10.1002/ccd.29592. Epub 2021 Mar 4.
8
Heart failure after myocardial infarction: incidence and predictors.心肌梗死后心力衰竭:发病率及预测因素
ESC Heart Fail. 2021 Feb;8(1):222-237. doi: 10.1002/ehf2.13144. Epub 2020 Dec 14.
9
Fractional flow reserve in clinical practice: from wire-based invasive measurement to image-based computation.临床实践中的血流储备分数:从基于导丝的侵入性测量到基于影像的计算
Eur Heart J. 2020 Sep 7;41(34):3271-3279. doi: 10.1093/eurheartj/ehz918.
10
Importance of infarct size versus other variables for clinical outcomes after PPCI in STEMI patients.梗死面积对 STEMI 患者 PPCI 后临床结局的重要性优于其他变量。
Basic Res Cardiol. 2019 Dec 12;115(1):4. doi: 10.1007/s00395-019-0764-8.